MIA:
- WHO ATC First Level (Anatomical main group) ID: J ANTIINFECTIVES FOR SYSTEMIC USE
- WHO ATC Second Level (Therapeutic subgroup) ID: J05 ANTIVIRALS FOR SYSTEMIC USE
- WHO ATC Third Level (Pharmacological subgroup) ID: J05A DIRECT ACTING ANTIVIRALS
- WHO ATC Fourth Level (Chemical subgroup) ID: J05AE Protease inhibitors
- WHO ATC Fifth Level (Chemical substance) ID: J05AE06 Lopinavir
- Chemical Name: Lopinavir
- Chemical Smi: O=C(N[C@H]([C@H](C[C@H](Cc1ccccc1)NC(=O)[C@@H](N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C
- WHO ICD Mapped Level : B23.0 B23.0 Name: Acute HIV infection syndrome
- WHO ICD Fourth Level ID: B23.0 B23.0 Name: Acute HIV infection syndrome
- WHO ICD Third Level ID: B23 B23 Name: Human immunodeficiency virus [HIV] disease resulting in other conditions
- WHO ICD Second Level ID: B20-B24 B20-B24 Name: Human immunodeficiency virus [HIV] disease
- WHO ICD First Level ID: I I Name: Certain infectious and parasitic diseases
|
|